Digestive Health

Digestive symptoms are among the most common reasons people in the UK see a clinician, and most are caused by conditions that can be managed well once they are properly identified. This guide walks through the main long-term digestive conditions — irritable bowel syndrome (IBS), gastro-oesophageal reflux disease (GORD), and functional dyspepsia — alongside travellers’ diarrhoea and the alarm symptoms that always warrant investigation. It explains how the UK medical pathway typically works, which treatment categories are used, and when self-management is enough versus when you need to see a clinician.

Understanding digestive health in plain English

The gut is a long, coordinated system stretching from the mouth to the anus, with acid, enzymes, hormones, nerves and trillions of microbes all working together. Symptoms such as bloating, reflux, indigestion, constipation or loose stools are rarely due to a single cause. In many people the gut is structurally normal but functioning uncomfortably — this is what clinicians mean by a “functional” disorder. Functional disorders are real, common, and often respond well to a combination of dietary change, lifestyle adjustment and, where needed, medication. They are not “all in the head”, although the gut-brain axis is genuinely part of the picture and stress can noticeably amplify symptoms.

Because digestive symptoms overlap so much, the first job of a UK clinician is to separate the common functional patterns from the smaller group of people who need urgent investigation for structural or inflammatory disease. That is the reason the NHS and NICE pathways ask about specific alarm features early on. Recognising these features early is what allows most people to receive reassurance and effective symptom management, while ensuring the smaller group with serious pathology is referred quickly.

A useful mental map is to group persistent digestive problems into three families: upper-gut (reflux, indigestion, functional dyspepsia), lower-gut (IBS, functional constipation, functional diarrhoea) and structural or inflammatory disease (peptic ulcer, coeliac, inflammatory bowel disease, cancer). These families often overlap in the same patient, and treatment usually addresses the dominant symptom pattern rather than a single diagnosis.

Irritable bowel syndrome (IBS)

IBS is diagnosed clinically using the Rome IV criteria: recurrent abdominal pain, on average at least one day a week for the previous three months, associated with defecation, a change in stool frequency or a change in stool form. Symptoms are usually grouped into IBS-C (constipation-predominant), IBS-D (diarrhoea-predominant), IBS-M (mixed) or IBS-U (unclassified). Common triggers include stress, poor sleep, certain fermentable carbohydrates, hormonal cycles and, in some people, specific food groups. Before a diagnosis of IBS is settled on, UK clinicians typically check for coeliac disease with a blood test, exclude anaemia and inflammation with basic bloods, and check a faecal calprotectin to help rule out inflammatory bowel disease. For a plain-English explainer of triggers and self-management, see IBS — understanding triggers and treatment.

UK first-line treatment focuses on general dietary and lifestyle measures: regular meals eaten without rushing, adequate fluid intake, limited caffeine and alcohol, and thoughtful adjustment of insoluble fibre such as bran. Physical activity, sleep hygiene and stress management have surprisingly strong evidence in IBS and are often underused. Where symptoms persist, a structured low-FODMAP approach delivered with a registered dietitian is the recognised second-line dietary intervention. It is a three-phase programme — restriction, systematic reintroduction, and personalisation — and is best not attempted long term without professional support.

Medication in IBS is used symptom-by-symptom rather than as a single “IBS drug”. Antispasmodics such as mebeverine, peppermint oil or hyoscine butylbromide can help with cramp. For IBS-C, soluble fibre such as ispaghula husk or a macrogol laxative is usually preferred over stimulant laxatives. For IBS-D, loperamide taken pre-emptively before meals or activities can be genuinely helpful, and short-term use of specific bile-acid modifiers may be considered in secondary care. Low-dose tricyclic antidepressants such as amitriptyline are used for pain in some patients when simpler options have not helped, at doses much lower than those used for depression. Psychological therapies including CBT and gut-directed hypnotherapy have a growing evidence base and are recommended by NICE for refractory symptoms.

Gastro-oesophageal reflux disease (GORD) and acid reflux

Occasional heartburn is common and often lifestyle-related. GORD is diagnosed when reflux is frequent or troublesome enough to affect quality of life or cause complications such as oesophagitis, stricture or Barrett’s oesophagus. Typical symptoms are burning behind the breastbone, an acid or bitter taste, night-time cough, hoarseness on waking and disturbed sleep. Some patients experience atypical presentations such as persistent throat clearing, dental erosion, or chest pain that must first be distinguished from cardiac pain. Lifestyle measures — weight management, smaller and earlier evening meals, avoiding late-night eating, reducing alcohol and smoking, and raising the head of the bed by roughly 15–20 cm — help many people, but a proportion need medication. Acid reflux — when lifestyle isn’t enough explains the escalation from self-care to prescribed therapy.

Two main drug classes are used. Proton pump inhibitors (PPIs) such as omeprazole, lansoprazole and esomeprazole reduce stomach acid production and are the mainstay of GORD treatment; a typical initial course is four to eight weeks, followed by a review to consider stepping down to the lowest effective dose or to an on-demand regimen. Full-dose PPIs are usually taken 30–60 minutes before the first meal of the day, which is a detail many patients are not told. H2-receptor antagonists such as famotidine reduce acid by a different mechanism and can be useful for on-demand or night-time breakthrough symptoms. Alginate-based antacids (for example, those containing sodium alginate) form a raft on top of stomach contents and are a helpful add-on, particularly for post-meal or postural reflux.

Long-term high-dose acid suppression should be reviewed periodically because of possible considerations around vitamin B12 and magnesium absorption, bone health and enteric infection risk, all detailed in the British National Formulary. For most patients the benefits of ongoing PPI treatment clearly outweigh these considerations, but the aim is always the lowest dose that controls symptoms. Patients who need continuous full-dose therapy for several months, or who develop alarm symptoms, are usually referred for upper GI endoscopy.

Functional dyspepsia

Functional dyspepsia is persistent or recurrent upper abdominal discomfort — a feeling of fullness after meals, early satiety, upper abdominal pain or burning — without an identified structural cause on investigation. It overlaps with reflux and IBS and often coexists with anxiety and stress. Two clinical patterns are recognised: postprandial distress syndrome, in which meals are the main trigger, and epigastric pain syndrome, in which pain or burning dominates. UK management typically starts with a test-and-treat approach for Helicobacter pylori in people under a certain age without alarm symptoms — this involves a stool antigen or breath test and, if positive, a short course of triple-therapy antibiotics. Where H. pylori is negative or symptoms persist, a trial of a PPI or H2 blocker is usual next step, and prokinetics may be considered in specialist care.

Symptom-focused dietary and behavioural changes often help alongside medication: smaller and more frequent meals, reduced fat and caffeine, avoiding trigger foods identified from a symptom diary, mindful eating without distraction, and attention to stress and sleep. Because functional dyspepsia can be relapsing, having a clear plan for flares — including when to restart short-term acid suppression and when to re-consult — is often more useful than aiming for a permanent “cure”.

Travellers’ diarrhoea

Travellers’ diarrhoea is the most common health problem affecting UK travellers to lower-income regions. It is usually caused by bacteria picked up from contaminated food or water, though viruses and parasites are also possible causes. Most episodes are self-limiting within three to five days. The mainstays of management are oral rehydration — sachets of oral rehydration salts are widely available and should be part of any traveller’s kit — and, in adults without red flags, short-term loperamide to reduce stool frequency during essential travel or activity. Prevention centres on sensible food and water choices: bottled or boiled water, well-cooked hot food, avoiding raw salads and unpasteurised dairy in higher-risk destinations, and consistent hand hygiene.

Antibiotics are reserved for more severe cases or specific high-risk groups such as travellers with significant comorbidities and should be prescribed by a clinician who has reviewed your itinerary, destinations and health history. Standby antibiotics are a specialist prescribing area because of the wider public-health implications of unnecessary antibiotic use. Seek medical review during or after travel if there is high fever, blood in the stools, severe abdominal pain, dehydration you cannot correct with fluids, or symptoms lasting more than a few days. Persistent post-travel bowel changes can occasionally reveal a parasitic infection or an underlying condition unmasked by travel, and should not be ignored.

Constipation and functional bowel habit change

Chronic constipation — infrequent stools, hard or lumpy stools, straining, a feeling of incomplete emptying — is one of the commonest reasons people seek advice from a UK pharmacy. First-line management is dietary: increasing soluble fibre (oats, fruit, ispaghula), adequate fluid intake, and regular physical activity, alongside protected time for the bowel to respond to the natural gastrocolic reflex after meals. Over-the-counter options include bulk-forming laxatives (ispaghula), osmotic laxatives (macrogols, lactulose) and stimulant laxatives (senna, bisacodyl) for short-term use. Macrogols are usually preferred for regular use because they are well tolerated and do not lose effect over time.

Persistent constipation with a change from your usual pattern, particularly after the age of 50 or with any bleeding, warrants clinical review rather than long-term self-treatment. Constipation can also be a side effect of common medicines — opioids, iron, some antidepressants and calcium supplements — and a medication review is often part of the picture.

The UK medical pathway

For most digestive symptoms in the UK, the first stop is your GP or a UK GPhC-registered pharmacy. The clinician will ask about symptom pattern, triggers, diet, medication history (including regular use of non-steroidal anti-inflammatories, which affect the stomach lining) and family history of bowel or stomach cancer. Basic blood tests to rule out anaemia, coeliac disease and inflammation, plus a stool test called faecal calprotectin, help separate functional from inflammatory bowel conditions. Where indicated, referral is made for endoscopy (gastroscopy or colonoscopy) under NICE pathways — particularly through the two-week wait suspected cancer route when alarm symptoms are present. Reliable, plain-English condition summaries are available on the NHS website.

When to seek urgent review — alarm symptoms

Some symptoms should never be self-managed and always need clinical assessment. The main alarm features are: unintentional weight loss, difficulty or pain on swallowing (dysphagia), persistent vomiting, blood in vomit or stools (including black, tarry stools), a new persistent change in bowel habit especially over the age of 50, a family history of bowel or stomach cancer at a younger age, or a lump felt in the upper abdomen. Iron-deficiency anaemia found on a blood test is another red flag, particularly in men and postmenopausal women. Nocturnal symptoms that wake you from sleep — particularly diarrhoea — are also unusual for a purely functional problem and should prompt review.

Any of these warrants same-week GP review, and severe upper abdominal pain, black stools or vomiting blood need same-day urgent care via NHS 111 or A&E. The purpose of investigation in these situations is not to alarm but to catch the small number of serious diagnoses early, when treatment is most effective. For most patients the tests come back reassuring and the focus can then return to symptom management.

Lifestyle foundations for gut health

Whichever condition you are working with, a small set of habits underpins nearly every UK digestive-health guideline. Eating regular meals at consistent times, chewing thoroughly and slowing down at the table gives the upper gut a chance to signal satiety and reduces the pressure that drives reflux. Adequate fluid — typically 1.5–2 litres a day for most adults, more with heat or exercise — supports normal bowel function. Regular physical activity and good sleep both improve gut motility, and reducing alcohol and stopping smoking help both reflux and long-term gut health. Stress management, whether through structured techniques, exercise or talking therapy, is not optional in functional gut disorders — it is part of the treatment.

Fibre deserves a specific mention. Most UK adults eat well below the 30 g per day target set by public health guidance. Increasing fibre gradually, favouring a mix of soluble and insoluble sources, and drinking enough water alongside it will improve stool consistency for most people. In IBS, however, some fibres worsen bloating — this is where a dietitian-supervised approach is particularly valuable.

How Farmeci fits in

Farmeci is a UK GPhC-registered online pharmacy. For digestive health our role is patient education and, where appropriate, a free clinician consultation to help you understand your symptoms, review over-the-counter options, and identify when a prescription or in-person GP assessment is needed. Common queries we help with include short-term reflux management, IBS symptom control, occasional constipation, and travel-related bowel upsets — all situations in which a pharmacy-led conversation can shorten the route to feeling better.

We do not diagnose serious disease online — if you have any alarm symptoms, we will point you to the appropriate NHS pathway rather than issue a treatment that could mask what is going on. The value of a properly delivered online consultation is not that it replaces face-to-face care, but that it gives you a clinician’s eyes on your history quickly, with clear next steps whether that means a treatment, a self-care plan, or a firm nudge to book a GP appointment. You can browse the full digestive health article library, read the related deep-dives on IBS triggers and treatment and acid reflux beyond lifestyle changes, and explore general wellbeing guides on sleep, stress and habits that strongly influence gut symptoms.